NASDAQ:MLYS (Mineralys Therapeutics)

About MLYS

Mineralys Therapeutics, Inc. s a clinical-stage biopharmaceutical company engaged in developing medicines to target disease, driven by abnormally elevated aldosterone. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
  • Mineralys Therapeutics (NASDAQ: MLYS) Latest News

    No posts found.